Reduced virulence in ciprofloxacin-resistant variants of Pseudomonas aeruginosa strains. 1987

G Ravizzola, and F Pirali, and A Paolucci, and L Terlenghi, and L Peroni, and A Colombi, and A Turano
Institute of Microbiology, University of Brescia, Italy.

Pseudomonas aeruginosa strains resistant to ciprofloxacin were obtained from parental strains by serial transfer through subinhibitory concentrations of the drug. They showed reduced virulence for mice, and also increased sensitivity to aminoglycosides.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

G Ravizzola, and F Pirali, and A Paolucci, and L Terlenghi, and L Peroni, and A Colombi, and A Turano
January 2010, Archives of microbiology,
G Ravizzola, and F Pirali, and A Paolucci, and L Terlenghi, and L Peroni, and A Colombi, and A Turano
February 1993, The Journal of antimicrobial chemotherapy,
G Ravizzola, and F Pirali, and A Paolucci, and L Terlenghi, and L Peroni, and A Colombi, and A Turano
January 1999, Antimicrobial agents and chemotherapy,
G Ravizzola, and F Pirali, and A Paolucci, and L Terlenghi, and L Peroni, and A Colombi, and A Turano
January 1989, Medical laboratory sciences,
G Ravizzola, and F Pirali, and A Paolucci, and L Terlenghi, and L Peroni, and A Colombi, and A Turano
October 1999, American journal of ophthalmology,
G Ravizzola, and F Pirali, and A Paolucci, and L Terlenghi, and L Peroni, and A Colombi, and A Turano
March 2023, Klinicka mikrobiologie a infekcni lekarstvi,
G Ravizzola, and F Pirali, and A Paolucci, and L Terlenghi, and L Peroni, and A Colombi, and A Turano
January 1978, The Journal of laboratory and clinical medicine,
G Ravizzola, and F Pirali, and A Paolucci, and L Terlenghi, and L Peroni, and A Colombi, and A Turano
December 2020, Antibiotics (Basel, Switzerland),
G Ravizzola, and F Pirali, and A Paolucci, and L Terlenghi, and L Peroni, and A Colombi, and A Turano
July 2005, Antimicrobial agents and chemotherapy,
G Ravizzola, and F Pirali, and A Paolucci, and L Terlenghi, and L Peroni, and A Colombi, and A Turano
September 1998, Archives of ophthalmology (Chicago, Ill. : 1960),
Copied contents to your clipboard!